Yes, promotion can be inhibited through various strategies. Chemopreventive agents and drugs that inhibit the action of promoters can be used to reduce cell proliferation and prevent the progression of precancerous cells to cancer. For example, selective estrogen receptor modulators (SERMs) can inhibit the proliferative effects of estrogens on breast tissue, thereby reducing the risk of breast cancer.
